Investigator Site - Manchester
Manchester MD20 4BX
0 studies enrolling now · 2 studies all time
What they study most
Breast Cancer, Colorectal Cancer, Metastasis
Studies at this site
- A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine — Completed
- NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer — Completed